Acute Mixed-Phenotype Leukemia
1 clinical trials · Condition
◉ Watch Acute Mixed-Phenotype Leukemia
| Record | Firm | Date |
|---|---|---|
| Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL (NCT05153330) | Biomea Fusion Inc. | 2022-01-24 |
Track Acute Mixed-Phenotype Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.